Filter results:

We want to pioneer 'deliberative dialogue' to involve a more diverse range of people in discussions about health challenges.  

Photo of the Datalabs team

Opinion | 21 March 2019

A new method for ethical data science by Danil Mikhailov

Wellcome Data Labs is applying a new method to solving data science problems to identify potential negative consequences of algorithms early on.

Young people are marching in protest at global leaders’ failure to tackle climate change. Howie Frumkin hopes that young people’s actions may shape all our futures.

Wellcome is making £2 million available to the WHO and government of DRC to support vaccine research as part of the emergency response to the Ebola outbreak.

illustration of influenza bacteria

Opinion | 1 March 2019

Vaccines work – for superbugs too by Ed Whiting

There's a vital set of tools to help us tackle the threat of superbugs that we're not using to their full potential. Vaccines.

Jim Smith seated at a round table listening to other people talking.

Opinion | 26 February 2019

How we’re approaching Wellcome’s science review by Jim Smith

We're working hard to clarify what we hope the science review will achieve, how we’ll carry it out and who we’ll speak to.

A woman scientist handling test tubes at UK Biobank.

Opinion | 19 February 2019

Open access and Plan S: how Wellcome is tackling four key concerns by Robert Kiley, David Carr

There has been lots of reaction to the changes we’re making to Wellcome’s open access policy. This is how we are addressing them.

A man being vaccinated in an Ebola vaccine trial in Liberia

Opinion | 15 February 2019

This is a pivotal moment for clinical trial regulations by Beth Thompson

Globally, clinical research is governed by guidelines established almost three decades ago. And Brexit is a looming issue for UK trials.

We’re launching two new calls to fund international exchange networks and infrastructure costs for humanities and social science researchers around the world.

Pages